CompuMed (OTCMKTS:CMPD) Shares Up 0.2% – Time to Buy?

CompuMed Inc. (OTCMKTS:CMPDGet Free Report) shares traded up 0.2% during mid-day trading on Wednesday . The stock traded as high as $6.20 and last traded at $6.20. 950 shares changed hands during trading, an increase of 72% from the average daily volume of 553 shares. The stock had previously closed at $6.19.

CompuMed Trading Up 0.2%

The company has a market cap of $8.25 million, a PE ratio of -41.33 and a beta of -0.47. The company has a current ratio of 2.37, a quick ratio of 2.34 and a debt-to-equity ratio of 0.12. The business has a 50 day simple moving average of $6.42 and a two-hundred day simple moving average of $5.50.

CompuMed (OTCMKTS:CMPDGet Free Report) last released its earnings results on Monday, May 11th. The company reported ($0.06) earnings per share for the quarter. The business had revenue of $2.03 million for the quarter. CompuMed had a negative return on equity of 6.47% and a negative net margin of 2.51%.

About CompuMed

(Get Free Report)

CompuMed, Inc, an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults.

Featured Stories

Receive News & Ratings for CompuMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CompuMed and related companies with MarketBeat.com's FREE daily email newsletter.